N-(3-Chloro-4-Fluorophenyl)-7-Fluoro-6-Nitroquinazolin-4-Amine CAS 162012-67-1 Maʻemaʻe >99.0% (HPLC) Afatinib Dimaleate Intermediate Factory

ʻO ka wehewehe pōkole:

Inoa Kemika: N-(3-Chloro-4-Fluorophenyl)-7-Fluoro-6-Nitroquinazolin-4-Amine

CAS: 162012-67-1

Maʻemaʻe: >99.0% (HPLC)

ʻAno: Melemele māmā i ka pauda melemele

Waena o Afatinib Dimaleate (CAS: 850140-73-7)

E-Mail: alvin@ruifuchem.com


Huahana Huahana

Nā Huahana Pili

Huahana Huahana

wehewehe:

Na Waiwai Kemika:

Inoa Kimia N-(3-Chloro-4-Fluorophenyl)-7-Fluoro-6-Nitroquinazolin-4-Amine
Nā huaʻōlelo like N-(3-Chloro-4-Fluorophenyl)-7-Fluoro-6-Nitro-4-Quinazolinamine;(3-Chloro-4-Fluorophenyl)(7-Fluoro-6-Nitroquinazolin-4-yl)amine;4-(3-Chloro-4-Fluoroanilino)-7-Fluoro-6-Nitroquinazoline;ʻO Afatinib Intermediate A
Helu CAS 162012-67-1
Helu CAT RF-PI2026
Kūlana Kūʻai Ma ka waihona, hoʻonui ʻia a hiki i nā tona
ʻĀpana Molekala C14H7ClF2N4O2
Kaumaha Molecular 336.68
ʻO ka ʻike Paʻi Lewa, Paʻa Wela
Lae hehee 242.0~244.0 ℃
Lae paila 489 ℃
ʻO ka mānoanoa 1.616
Brand Kemika Ruifu

Nā kikoʻī:

'ikamu Nā kikoʻī
Ka nana aku Melemele māmā i ka pauda melemele
Maʻemaʻe / Kaʻina Hanana >99.0% (HPLC)
Nalo ma ka maloo <0.50%
Koena ma ka Ignition <0.20%
Na mea pili
Ka haumia o ke kanaka <0.50%
Huina paumaele <1.00%
Nā Metala Kaumaha ≤20ppm
Infrared Spectrum Kūlike i ka hoʻolālā
Proton NMR Spectrum Kūlike i ka hoʻolālā
Kūlana hoʻāʻo Kūlana ʻoihana
Hoʻohana Waena o Afatinib Dimaleate (CAS: 850140-73-7)

Pūʻolo a me ka waiho ʻana:

Pūʻolo: ʻOmole, ʻeke ʻeke Aluminum, 25kg / pahu pahu pahu, a i ʻole e like me ka makemake o ka mea kūʻai aku.

Kūlana mālama:E mālama i loko o nā pahu i hoʻopaʻa ʻia ma kahi maloʻo a maloʻo;E pale i ka malamalama a me ka wai

Pono:

1

FAQ:

Noi:

ʻO N-(3-Chloro-4-Fluorophenyl)-7-Fluoro-6-Nitroquinazolin-4-Amine (CAS: 162012-67-1) he mea waena i ka synthesis o Afatinib Dimaleate (CAS: 850140-73-7) .ʻO Afatinib Dimaleate kahi ʻano paʻakai o Afatinib.ʻO Afatinib ka lua o ka hanauna, i lawelawe waha ʻia, i hoʻohuli ʻole ʻia o ka ʻohana ErbB o tyrosine kinases.Mechanism of ActionAfatinib downregulates ErbB signing by covalently binding to the kinase domains of epidermal growth factor receptor (EGFR), human epidermal growth factor receptor (HER) 2 a me HER4, ka hopena i ka hiki ole ke hoʻololi i ka tyrosine kinase autophosphorylation;ke kaʻe nei i ka transphosphorylation o HER3.Ua ʻae ʻia ʻo Afatinib ma ke ʻano he monotherapy no ka mālama ʻana i ka EGFR tyrosine kinase inhibitor (TKI) -naive adults me locally advanced or DefinitionChEBI: He paʻakai maleate i loaʻa ma ka hoʻohui ʻana i ka afatinib me ʻelua mau molar like o ka maleic acid.Hoʻohana ʻia no ka lāʻau lapaʻau mua o nā poʻe maʻi me ka maʻi maʻi ʻaʻa ʻole liʻiliʻi liʻiliʻi metastatic.

E kākau i kāu leka ma aneʻi a hoʻouna mai iā mākou